Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.

Abstract	Two triphasic oral contraceptives containing either gestodene or norethindrone as the progestogenic compound combined with ethinyl estradiol were compared in a randomized clinical trial to assess their contraceptive reliability, clinical tolerance and cycle control. Both preparations were effective in preventing pregnancy. The gestodene preparation proved significantly superior regarding cycle control and general tolerance.
Authors	F Weber-Diehl, J Lehnert, U Lachnit
Journal	Contraception (Contraception) Vol. 48 Issue 4 Pg. 291-301 (Oct 1993) ISSN: 0010-7824 [Print] United States
PMID	8222658 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References	Contraceptives, Oral, Combined Norpregnenes Progesterone Congeners Gestodene Norethindrone
Topics	Acne Vulgaris (chemically induced) Adult Contraceptives, Oral, Combined (adverse effects, pharmacology) Female Headache (chemically induced) Humans Menstrual Cycle (drug effects) Middle Aged Norethindrone (administration & dosage, adverse effects, pharmacology) Norpregnenes (administration & dosage, adverse effects, pharmacology) Patient Dropouts Progesterone Congeners (administration & dosage, adverse effects, pharmacology) Weight Gain (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!